Please Wait.....
Report
Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2025-2033
Market Report I 2025-04-01 I 149 Pages I IMARC Group
The global pediatric vaccines market size reached USD 39.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 72.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.89% during 2025-2033. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.
Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.
At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.
Pediatric Vaccines Market Trends/Drivers:
Growing conduction of vaccination programs
The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.
Increasing focus on combination vaccines
The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.
Rising development of novel vaccines
The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.
Pediatric Vaccines Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global pediatric vaccines market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on type, technology, and application.
Breakup by Type:
- Multivalent
- Monovalent
Multivalent dominates the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes multivalent and monovalent. According to the report, multivalent represented the largest segment.
Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.
Breakup by Technology:
- Conjugate
- Live Attenuated
- Inactivated
- Subunit
- Toxoid
- Others
Conjugate holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes conjugate, live attenuated, inactivated, subunit, toxoid, and others. According to the report, conjugate accounted for the largest market share.
Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.
Breakup by Application:
- Infectious Disease
- Cancer
- Allergy
- Others
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes infectious disease, cancer, allergy, and others.
Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.
Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.
Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.
Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.
Competitive Landscape:
Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Abbott Laboratories
- Bio-Med Private Limited
- Daiichi Sankyo Company Limited
- GSK plc
- Indian Immunologicals Limited (National Dairy Development Board)
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
- Panacea Biotec Limited
- Pfizer Inc.
- Sanofi S.A.
- Sinovac Biotech Ltd.
Key Questions Answered in This Report
1.What was the size of the global pediatric vaccines market in 2024?
2.What is the expected growth rate of the global pediatric vaccines market during 2025-2033?
3.What are the key factors driving the global pediatric vaccines market?
4.What has been the impact of COVID-19 on the global pediatric vaccines market?
5.What is the breakup of the global pediatric vaccines market based on the type?
6.What is the breakup of the global pediatric vaccines market based on the technology?
7.What are the key regions in the global pediatric vaccines market?
8.Who are the key players/companies in the global pediatric vaccines market?
?1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pediatric Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Multivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Monovalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Conjugate
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Live Attenuated
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inactivated
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Subunit
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Toxoid
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Disease
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Med Private Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 GSK plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Panacea Biotec Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sinovac Biotech Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2024
Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2024
Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2024
Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2024
Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis
Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Pediatric Vaccines Market: Competitive Structure
Table 7: Global: Pediatric Vaccines Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security